论文部分内容阅读
我国是乙型肝炎的高发地区,慢性乙型肝炎的病人很多,但一直没有较好的治疗方法。我们曾承担国家“六五”、“七五”“慢性肝炎治疗研究”的攻关任务,发现了一些新的治疗方法,其疗效不亚于目前国内外公认的有一定疗效的干扰素疗法,而价格则便宜得多,仅为干扰素疗法的1/10～1/20。其中尤以猪苓多糖加乙肝疫苗的疗效似更好一些。现将情况简单介绍如下(见附表)。
China is a high incidence of hepatitis B, a lot of patients with chronic hepatitis B, but there is no better treatment. We have undertaken the research task of “Sixth Five-Year Plan” and “Seventy-Five” “Chronic Hepatitis Treatment Study” and found some new treatment methods that are as effective as the currently recognized interferon therapy with certain curative effect at home and abroad. However, The price is much cheaper, only interferon therapy 1/10 ~ 1/20. In particular, Polyporus polysaccharide plus hepatitis B vaccine efficacy seems to be better. Now the situation is briefly described below (see attached table).